Display options
Cite
King JM, Kulhankova K, Stach CS, et al. Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages. mSphere. 2016;1(3)doi: 10.1128/mSphere.00071-16.
King, J. M., Kulhankova, K., Stach, C. S., Vu, B. G., & Salgado-Pabón, W. (2016). Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages. mSphere, 1(3), . https://doi.org/10.1128/mSphere.00071-16
King, Jessica M, et al. "Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages." mSphere vol. 1,3 (2016). doi: https://doi.org/10.1128/mSphere.00071-16
King JM, Kulhankova K, Stach CS, Vu BG, Salgado-Pabón W. Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages. mSphere. 2016 Jun 08;1(3). doi: 10.1128/mSphere.00071-16. eCollection 2016. PMID: 27303750; PMCID: PMC4899884.
Copy Download .nbib Format: NLM
Share it on

mSphere. 2016 Jun 08;1(3). doi: 10.1128/mSphere.00071-16. eCollection 2016.

Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages.

mSphere

Jessica M King, Katarina Kulhankova, Christopher S Stach, Bao G Vu, Wilmara Salgado-Pabón

Affiliations

  1. Department of Microbiology, University of Iowa, Carver College of Medicine, Iowa City, Iowa, USA.

PMID: 27303750 PMCID: PMC4899884 DOI: 10.1128/mSphere.00071-16

Abstract

Staphylococcus aureus diseases affect ~500,000 individuals per year in the United States. Worldwide, the USA100, USA200, USA400, and USA600 lineages cause many of the life-threatening S. aureus infections, such as bacteremia, infective endocarditis, pneumonia, toxic shock syndrome, and surgical site infections. However, the virulence mechanisms associated with these clonal lineages, in particular the USA100 and USA600 isolates, have been severely understudied. We investigated the virulence of these strains, in addition to strains in the USA200, USA300, and USA400 types, in well-established in vitro assays and in vivo in the rabbit model of infective endocarditis and sepsis. We show in the infective endocarditis and sepsis model that strains in the USA100 and USA600 lineages cause high lethality and are proficient in causing native valve infective endocarditis. Strains with high cytolytic activity or producing toxic shock syndrome toxin 1 (TSST-1) or staphylococcal enterotoxin C (SEC) caused lethal sepsis, even with low cytolytic activity. Strains in the USA100, USA200, USA400, and USA600 lineages consistently contained genes that encode for the enterotoxin gene cluster proteins, SEC, or TSST-1 and were proficient at causing infective endocarditis, while the USA300 strains lacked these toxins and were deficient in promoting vegetation growth. The USA100, USA200, and USA400 strains in our collection formed strong biofilms in vitro, whereas the USA200 and USA600 strains exhibited increased blood survival. Hence, infective endocarditis and lethal sepsis are multifactorial and not intrinsic to any one individual clonal group, further highlighting the importance of expanding our knowledge of S. aureus pathogenesis to clonal lineages causative of invasive disease. IMPORTANCE S. aureus is the leading cause of infective endocarditis in the developed world, affecting ~40,000 individuals each year in the United States, and the second leading cause of bacteremia (D. R. Murdoch et al., Arch Intern Med 169:463-473, 2009, http://dx.doi.org/10.1001/archinternmed.2008.603, and H. Wisplinghoff et al., Clin Infect Dis 39:309-317, 2004, http://dx.doi.org/10.1086/421946). Even with current medical advances, S. aureus bloodstream infections and infective endocarditis carry mortality rates of 20 to 66% (S. Y. Tong et al., Clin Microbiol Rev 28:603-661, 2015, http://dx.doi.org/10.1128/CMR.00134-14). S. aureus lineages associated with human disease worldwide include clonal complex 5 (CC5)/USA100, CC30/USA200, CC8/USA300, CC1/USA400, and CC45/USA600. The CC5/USA100, CC30/USA200, and CC45/USA600 lineages cause invasive disease yet remain poorly characterized. USA300 and cytotoxins are central to most S. aureus virulence studies, and yet, we find evidence that clonal groups are quite heterogeneous in parameters canonically used to measure virulence, including cytotoxicity, biofilm formation, and blood survival, and that the superantigen profile is an important parameter to consider when defining the virulence of S. aureus strains.

Keywords: Staphylococcus aureus; infective endocarditis; rabbit model; sepsis; superantigens; virulence factors

References

  1. J Infect Dis. 2014 Sep 1;210(5):784-92 - PubMed
  2. J Clin Microbiol. 2010 Jun;48(6):2307-10 - PubMed
  3. JAMA. 2005 Jun 22;293(24):3012-21 - PubMed
  4. PLoS One. 2011;6(8):e22997 - PubMed
  5. J Clin Microbiol. 2009 Jun;47(6):1733-41 - PubMed
  6. Arch Intern Med. 2009 Mar 9;169(5):463-73 - PubMed
  7. FEBS J. 2011 Dec;278(23):4649-67 - PubMed
  8. Clin Microbiol Rev. 2000 Jan;13(1):16-34, table of contents - PubMed
  9. Infect Immun. 2014 Apr;82(4):1559-71 - PubMed
  10. Nat Rev Microbiol. 2014 Aug;12 (8):585-91 - PubMed
  11. MMWR Morb Mortal Wkly Rep. 1999 Aug 20;48(32):707-10 - PubMed
  12. JAMA. 2007 Oct 17;298(15):1763-71 - PubMed
  13. Methods Mol Biol. 2014;1085:169-85 - PubMed
  14. J Infect Dis. 2011 Sep 1;204(5):704-13 - PubMed
  15. J Infect Dis. 2015 Jun 15;211(12):1862-74 - PubMed
  16. J Immunol. 2001 Jan 1;166(1):669-77 - PubMed
  17. Clin Microbiol Rev. 2015 Jul;28(3):603-61 - PubMed
  18. Infect Immun. 2013 Sep;81(9):3227-38 - PubMed
  19. PLoS Biol. 2015 Sep 02;13(9):e1002229 - PubMed
  20. Nat Methods. 2012 Jul;9(7):671-5 - PubMed
  21. Genome Announc. 2013 Jul 25;1(4):null - PubMed
  22. Springerplus. 2013 Dec;2(1):133 - PubMed
  23. J Clin Microbiol. 2014 Jul;52(7):2439-46 - PubMed
  24. J Bacteriol. 2007 Oct;189(20):7515-9 - PubMed
  25. Clin Microbiol Rev. 2013 Jul;26(3):422-47 - PubMed
  26. Emerg Infect Dis. 2007 Dec;13(12):1840-6 - PubMed
  27. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12828-31 - PubMed
  28. J Clin Microbiol. 2013 Mar;51(3):914-9 - PubMed
  29. J Infect Dis. 2007 Sep 1;196(5):738-47 - PubMed
  30. PLoS One. 2012;7(12):e51172 - PubMed
  31. J Clin Microbiol. 2008 Sep;46(9):2837-41 - PubMed
  32. Proc Natl Acad Sci U S A. 2002 May 28;99(11):7687-92 - PubMed
  33. Euro Surveill. 2010 Oct 14;15(41):19688 - PubMed
  34. Clin Infect Dis. 2012 Jul;55(2):232-41 - PubMed
  35. MBio. 2013 Aug 20;4(4):null - PubMed
  36. Kidney Int. 2005 Mar;67(3):1084-92 - PubMed
  37. J Clin Microbiol. 2014 Jun;52(6):2172-4 - PubMed
  38. Clin Infect Dis. 2004 Aug 1;39(3):309-17 - PubMed
  39. J Clin Microbiol. 2009 May;47(5):1344-51 - PubMed
  40. J Gen Microbiol. 1965 Aug;40(2):283-96 - PubMed
  41. Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18091-6 - PubMed
  42. PLoS One. 2013;8(3):e60033 - PubMed
  43. Methods Mol Biol. 2016;1396:73-80 - PubMed
  44. BMC Genomics. 2014 Dec 19;15:1145 - PubMed
  45. Nature. 1963 Jun 15;198:1091-2 - PubMed
  46. Proc Natl Acad Sci U S A. 1990 Jan;87(1):225-9 - PubMed
  47. Crit Care Med. 2006 Oct;34(10):2588-95 - PubMed
  48. Front Cell Infect Microbiol. 2012 Feb 21;2:18 - PubMed
  49. JAMA. 1999 Sep 22-29;282(12):1123-5 - PubMed
  50. Open Forum Infect Dis. 2015 Jun 24;2(3):ofv093 - PubMed
  51. N Engl J Med. 1998 Aug 20;339(8):520-32 - PubMed
  52. J Infect Dis. 2014 Dec 15;210(12):1920-7 - PubMed

Publication Types

Grant support